TipRanks
Go Ultimate55% OFF

Viking Therapeutics (1VT) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Vk2735 DrugObese AdultsPhase IRecruitingA Phase 1 Study of VK2735 in Obese Adults Without ComorbiditiesSep 09, 2026―
Vk2735Weight LossPhase IIIRecruitingVK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)Jul 29, 2025
Vk2735Weight LossPhase IIIRecruitingVK2735 for Weight Management Phase 3Jul 29, 2025
Vk2735Weight LossPhase IICompletedVK2735 for Weight Management Phase 2 (Venture Oral Dosing)Feb 10, 2025―
Vk2735Weight LossPhase IICompletedVK2735 for Weight Management Phase 2Sep 28, 2023―
Vk2735, Vk2735 DrugWeight Loss, NashPhase ICompletedPhase 1 Study to Evaluate the Safety and Tolerability of VK2735Jan 10, 2022―
Vk0214Adrenomyeloneuropathy Form (Amn) Of X-Linked Adrenoleukodystrophy (X-Ald)Phase ICompletedA Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMNJun 28, 2021―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Viking Therapeutics (DE:1VT) have in its pipeline
Viking Therapeutics DE:1VT is currently developing the following drugs: Vk2735 Drug, Vk2735, Vk2735, Vk2735 Drug, Vk0214. These drug candidates are in various stages of clinical development as the company works toward FDA approval.